The deal has most likely been axed due to the uncertainty wrought by the Trump admin’s tariffs. Image credit: Andrii Yalanskyi via Shutterstock

由于特朗普政府的关税带来的不确定性，这笔交易很可能已被取消。图片来源：Andrii Yalanskyi 通过 Shutterstock

France-based Keensight Capital has axed plans to acquire British medical device manufacturer Niox Group.

总部位于法国的Keensight Capital已经取消了收购英国医疗器械制造商Niox Group的计划。

Last month, the private equity firm tabled a cash offer to acquire Niox for around £22.4m ($29.1m), equating to 81p per share, up from its originally proposed offer of 78p.

上个月，这家私人股本公司提出了一项现金收购要约，以约2240万英镑（2910万美元）的价格收购Niox，相当于每股81便士，高于其最初提出的78便士的报价。

Go deeper with GlobalData

深入探索GlobalData

Reports

报告

ICP Monitoring Devices Market Size (Value, Volume, ASP) by Segments...

ICP监测设备市场规模（价值、数量、平均售价）按细分市场...

Reports

报告

Medical Devices Industry Mergers and Acquisitions Deals by Top Them...

医疗器械行业并购交易的主题分布

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

Niox develops a point-of-care device that measures asthma biomarker fractional exhaled nitric oxide (FeNO). In a brief statement issued on 11 April, Keensight said it no longer intended to make a firm offer on Niox in light of the “current macro-economic backdrop”.

Niox开发了一种床旁诊断设备，用于测量哮喘生物标志物呼出气一氧化氮分数（FeNO）。Keensight在4月11日发布的简短声明中表示，鉴于“当前的宏观经济背景”，它不再打算对Niox提出确定的收购要约。

Doubtless alluding to President Trump’s announcement of tariffs for the majority of the US’s trading partners this month, Keensight is far from the only company affected by the GOP’s injurious approach to trade policy, which Wall Street analysts fear could precipitate a US recession.

毫无疑问，这指的是特朗普总统本月宣布的针对美国大部分贸易伙伴的关税政策。凯恩赛特远非唯一一家受到共和党这种有害的贸易政策影响的公司，华尔街分析师担忧这可能会引发美国经济衰退。

On 9 April, tariffs for most countries, including China, Japan, and the EU as a collective bloc, were due to go into effect. However, barring China, which has been hit with tariff increases of 125% on US imports, the Trump administration tapped the brakes and instead announced there would be a three-month pause on the imposition of the tariffs, bringing a close (for now) to a lacerating stretch that has wiped around $10trn from the global stock markets..

4月9日，包括中国、日本和欧盟在内的大多数国家的关税即将生效。但是，除了中国——美国对中国的进口产品征收了125%的关税——特朗普政府踩了刹车，宣布将暂缓三个月实施关税，暂时结束了令全球股市蒸发约10万亿美元的痛苦期。

For the major players in the medtech industry,

对于医疗技术行业的主要参与者，

share prices have been driven

股价已经被推动

by the uncertainty stoked by the Trump administration’s ‘at-a-whim’ approach to trade policy. On 9 April, shares in GE HealthCare, which is heavily reliant on the Chinese market, opened a further 1.6% down at $57.79, meaning it is now trading 38% lower than the 2025 market open high in mid-February..

由于特朗普政府“随心所欲”的贸易政策引发的不确定性，4月9日，严重依赖中国市场的GE医疗公司股价开盘进一步下跌1.6%，至57.79美元，这意味着其目前的交易价格比2025年2月中旬创下的市场开盘高点低了38%。

Other major players in the space, including Boston Scientific, Medtronic, and Johnson & Johnson, were all trading 6%-8% down at market open on 9 April in contrast to prices last month.

包括波士顿科学、美敦力和强生在内的该领域的其他主要参与者，4月9日开盘时均较上个月的价格下跌了6%-8%。

British portable oxygenator developer Belluscura reported it was

英国便携式氧合器开发商贝尔卢斯库拉公司报告称

scrapping its 2025 revenue guidance

取消其2025年收入预测

due to the tariffs, given that a “significant proportion” of the company’s portable oxygen concentrators, raw materials and components are currently manufactured in China. The announcement caused Belluscura’s stock price to crash by almost 50%.

由于关税的原因，鉴于该公司“很大一部分”便携式氧气浓缩器、原材料和组件目前在中国制造。该公告导致贝尔斯库拉的股价暴跌近50%。

On 10 April, Advanced Medical Technology Association (AdvaMed) CEO Scott Whitaker said

4月10日，先进医疗技术协会（AdvaMed）首席执行官斯科特·惠特克表示

the association was ‘encouraged’ by the tariff pause

协会对关税暂停感到“鼓舞”。

, and repeated his hope that AdvaMed could work with the Trump administration to obtain a tariff exemption for the medtech industry.

，并重申了他希望 AdvaMed 能与特朗普政府合作，为医疗技术行业争取到关税豁免。

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

通过我们领先的行业洞察，为您的企业带来优势。

Sign up

注册

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到 Facebook